-
TPST Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Tempest Therapeutics (TPST)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 22.91 mm | 22.91 mm | 22.91 mm | 22.91 mm | 22.91 mm | 22.91 mm |
Cash burn (monthly) | 3.29 mm | (no burn) | 3.52 mm | 2.72 mm | 3.52 mm | 2.53 mm |
Cash used (since last report) | 9.25 mm | n/a | 9.91 mm | 7.66 mm | 9.91 mm | 7.14 mm |
Cash remaining | 13.66 mm | n/a | 13.01 mm | 15.25 mm | 13.00 mm | 15.78 mm |
Runway (months of cash) | 4.2 | n/a | 3.7 | 5.6 | 3.7 | 6.2 |
13F holders | Current |
---|---|
Total holders | 25 |
Opened positions | 8 |
Closed positions | 2 |
Increased positions | 6 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 4.74 bn |
Total shares | 6.17 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Versant Venture Capital VI | 2.12 mm | $7.65 mm |
EcoR1 Capital | 1.12 mm | $1.43 bn |
FMR | 647.90 k | $822.83 mm |
Rock Springs Capital Management | 536.21 k | $680.99 mm |
AIGH Capital Management | 406.25 k | $515.94 mm |
Vanguard | 309.84 k | $393.50 mm |
Sectoral Asset Management | 219.39 k | $278.63 mm |
LAV Regulus | 153.74 k | $812.00 k |
FIL | 129.58 k | $164.57 mm |
Renaissance Technologies | 103.40 k | $131.00 k |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Jul 24 | Stephen R Brady | Common Stock | Buy | Acquire P | No | No | 2.11 | 35,000 | 73.85 k | 46,376 |
2 Jul 24 | Samuel Whiting | Common Stock | Buy | Acquire P | No | No | 2.13 | 4,672 | 9.95 k | 9,573 |
28 Jun 24 | Justin Trojanowski | Common Stock | Buy | Acquire P | No | No | 2.16 | 7,500 | 16.20 k | 22,168 |
13 Jun 24 | Nichol Geoffrey | Stock Option Common Stock | Grant | Acquire A | No | No | 3.03 | 16,000 | 48.48 k | 16,000 |
13 Jun 24 | Michael Raab | Stock Option Common Stock | Grant | Acquire A | No | No | 3.03 | 16,000 | 48.48 k | 16,000 |